Craig-Hallum Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
Contract Pharma16h
TriLink, Avantor Team Up to Expand Nucleic Acid Access in EMEA
TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...
Avantor, TriLink BioTechnologies partner on nucleic acid solutions in Europe
TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
American Association of Individual Investors4d
3 Undervalued Life Sciences Tools & Services Stocks for Thursday, January 30
Discover the top 3 undervalued Life Sciences Tools & Services stocks for Thursday, January 30 based on AAII’s Stock Grades.
Business Wire6d
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...
Maravai LifeSciences expands mRNA manufacturing with new acquisition
SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...